Mankind Pharma share price surged 2% after Morgan Stanley initiated coverage with an 'Overweight' rating and a Rs 2,500 target price, citin...

The company reported an 8% year-on-year rise in Q3FY26 net profit to Rs 414 crore, while revenue grew 11.5% to Rs 3,567 crore, led by solid...

Mankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue growth of 24%. ...

Mankind Pharma has appointed Barclays and Deutsche Bank to arrange financing for its Rs 13,630 crore acquisition of Bharat Serums & Vaccine...

Mankind Pharma Share Price: Mankind Pharma shares dropped by 2.5% following the announcement of a Rs 13,630 crore acquisition of Bharat Ser...

Mankind Pharma announced its acquisition of Bharat Serums and Vaccines Limited (BSV) from Advent International for approximately Rs 13,630 ...

Mankind Pharma is in talks to acquire Bharat Serums & Vaccines Ltd., a biopharmaceutical company with brands like Manforce Condoms and Preg...

PE firm ChrysCapital's affiliate entity Beige Ltd was reported to have issued a term sheet via its broker to sell up to 1.16 crore shares o...

Mankind Pharma, which recently made its stock exchange debut, has been added to several Nifty indices, including Nifty500 and Nifty Midcap1...

Shares of Mankind Pharma fell more than 6%, a day after its listing on the Indian stock exchanges at a premium. The company's IPO was the l...

Its shares are currently trading nearly 6.7% higher at Rs 1,387. The IPO received a strong response, with the issue subscribed for 15.32 ti...

The IPO, valued at Rs 4,326 crore, received an overwhelming response, being subscribed for 15.32 times due to interest from qualified insti...

Mankind Pharma's Rs 4,326 crore initial public offering (IPO), the largest by a domestic drug maker so far in 2021 and with a 15.32 times s...

Around nine brokerages have given "subscribe" recommendations on the issue, with some of them seeing the potential in the long term. Analys...

The Rs 4,300-crore IPO, solely an offer for sale (OFS), will be available for public to bid till April 27. Investors can bid for 13 shares ...

The company has fixed a price band of Rs 1,026-1,080 for its IPO, which is completely an offer for sale (OFS) of 40 million equity shares b...

The company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...